SEC Form 4 · accession 0001493152-18-008527
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Mitgang
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 12, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $4.30 | Jun 8, 2018 | A | 400 | A | Jul 8, 2018 | Jun 7, 2028 | Common Stock | 400 | 400 | D |
Explanation of responses
- F1Stock option granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan. The options vest and become exercisable in 12 equal monthly installments from the date of grant.